TrialClinical pharmacology and therapeutics2020

Dose-Dependent Inhibition of OATP1B by Rifampicin in Healthy Volunteers: Comprehensive Evaluation of Candidate Biomarkers and OATP1B Probe Drugs.

Daiki Mori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.